[Correlation between metabolic syndrome and prognosis of patients with clear cell renal cell carcinoma].

OBJECTIVE

To investigate the effects of MetS on the prognosis of patients with clear cell renal cell carcinoma (ccRCC).

METHODS

Clinical and pathological data and the laboratory test of ccRCC 342 patients with diverticular stones who underwent ccRCC who underwent radical or partial nephrectomy were retrospectively collected and analyzed.The patients were divided into MetS group and non-MetS group, and the subgroups were defined according to the tumor size. The overall survival (OS), cancer-specific survival (CSS), and progression-free survival (PFS) of the two groups were analyzed by univariate Cox analysis, and the subgroup analyses were also performed. Kaplan-Meier survival curve and survival analysis for OS, CSS, and PFS of the two groups and the subgroups were conducted.

RESULTS

Univariate Cox analysis showed that MetS was a protective factor of postoperative OS [hazard ratio ()=0.551, 95%: 0.321-0.949, =0.031], CSS (=0.460, 95%: 0.234-0.905, =0.025), and PFS (HR 0.585, 95%: 0.343-0.998, =0.049) in the patients with ccRCC. In the subgroup with tumor size≤4 cm, MetS was not associated with postoperative OS (=0.857, 95%: 0.389-1.890, =0.702), CSS (=1.129, 95%: 0.364-3.502, =0.833), and PFS (=1.554, 95%: 0.625-3.864, =0.343). In the subgroup with tumor size>4 cm, Mets was a protective factor of postoperative OS (HR=0.377, 95%: 0.175-0.812, 0.013), CSS (=0.280, 95%: 0.113-0.690, =0.006), and PFS (=0.332, 95%: 0.157-0.659, =0.002); Obesity was a protective factor of postoperative CSS (=0.464, 95%: 0.219-0.981, =0.044), and PFS (=0.445, 95%: 0.238-0.833, =0.011). Kaplan-Meier survival analysis showed that the long-term survival of patients with MetS was better than those without MetS in OS (=0.029), CSS (=0.021), and PFS (0.046); for the subgroup with tumor size≤4 cm, there was no significant difference in postoperative OS (=0.702), CSS (=0.833), and PFS (=0.339) between patients with and without MetS; For the subgroup with tumor size>4 cm, the OS (=0.010), CSS (0.003), and PFS (=0.001) of patients with MetS were better than those without MetS.

CONCLUSION

MetS was a protective factor of postoperative OS, CSS, and PFS in the patients with ccRCC, which was more obvious in subgroup with tumor size>4 cm. And obesity, the component of MetS, was correlated with postoperative OS and CSS.